Advertisement

Zentrales Nervensystem und Sinnesorgane

  • R. Engenhart-Cabillic
  • M. W. Groß
  • M. Henzel
  • A. Zabel-du Bois
  • S. Milker-Zabel
  • D. Rades
Chapter

Zusammenfassung

Vergleicht man die Inzidenzzahlen der letzten Jahre, so findet man eine große Varianz mit Angaben zwischen 9–12 pro 100 000 Einwohner pro Jahr.

Literatur

  1. Agarwala SS, Kirkwood JM, Gore M et al. (2004) Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study. J Clin Oncol 22: 2101–2107PubMedGoogle Scholar
  2. Alapetite C, Brisse H, Patte C, et al. (2010) Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience. Neuro Oncol 12(12): 1318–1325PubMedGoogle Scholar
  3. Amatya VJ, Takeshima Y, Inai K (2004) Methylation of p14(ARF) gene in meningiomas and its correlation to the p53 expression and mutation. Mod Pathol 17(6):705–710PubMedGoogle Scholar
  4. Andrews DW, Suarez O, Goldman HW et al. (2001) Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution. Int J Radiat Oncol Biol Phys 50(5):1265–1278PubMedGoogle Scholar
  5. Andrews DW, Faroozan R, Yang BP et al. (2002) Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgery. Neurosurgery 51(4): 890–904PubMedGoogle Scholar
  6. Andrews DW, Scott CB, Sperduto PW et al. (2004) Whole brain radiation therapy with or without stereotactic boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomized trial. Lancet 363:1665–1672PubMedGoogle Scholar
  7. Ang KK, Price RE, Stephens LC, Jiang GL, Feng Y, Schultheiss TE, Peters LJ (1993) The tolerance of primate spinal cord to re-irradiation. Int J Radiat Oncol Biol Phys 25:469–464Google Scholar
  8. Antonadou D, Coliarakis N, Paraskevaidis M et al. (2002) Whole brain radiotherapy alone or in combination with temozolomide for brain metastases. A phase III study. Int J Radiat Oncol Biol Phys 54 (Suppl 2):156Google Scholar
  9. Aupérin A, Arriagada R, Pignon JP et al. (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. NEJ 341:476–484Google Scholar
  10. Ball WS, Prenger EC, Ballard RT (1992) Neurotoxicity of Radio/Chemotherapy in children: pathologic and MR correlation. Am J Neuroradiol 13:761–776PubMedGoogle Scholar
  11. Bamberg M, Kortmann RD, Engenhart-Cabillic R et al. (1999 a) DEGRO-Leitlinie R16: Radiotherapie von primären Tumoren des Zentralnervensystems und ZNS-Metastasen im Erwachsenenalter. Oktober 1999Google Scholar
  12. Bamberg M, Kortmann RD, Calaminus G, Becker G, Meisner CH, Harms D, Göbel U (1999 b) Radiation therapy for intracranial germinoma: Results of the German Cooperative Prospective Trials MAKEI 83/86/89. J Clin Oncol 17:2585–2592PubMedGoogle Scholar
  13. Bataini JP, Delenian S, Ponvert D (1991) Chiasmal glioma: Results of irradiation managment in 57 patients and review of the literature. Int J Radiat Oncol Biol Phys 21:615–623PubMedGoogle Scholar
  14. Becker G, Kortmann RD, Skalej M, Bamberg M (1999) The role of radiotherapy in the treatment of craniopharyngioma – indications, results, side effects. Front Radiat Ther Oncol 33:100–113PubMedGoogle Scholar
  15. Becker G, Jeremic B, Pitz S et al. (2002) Stereotactic fractionated radiotherapy in patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 54(5):1422–1429PubMedGoogle Scholar
  16. Benes V III, Barsa P, Benes V Jr et al. (2009) Prognostic factors in intramedullary astrocytomas: a literature review. Eur J Spine 18:1397–1422Google Scholar
  17. van den Bent MJ, Afra D, de Witte O et al. (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366: 985–990PubMedGoogle Scholar
  18. van den Bent MJ, Brandes AA, Taphoorn MJB, Kros JM, Kouwenhoven MCM, Delattre J-Y, Bernsen HJJA, Frenay M, Tijssen CC, Grisold W, Sipos L, Enting RH, French PJ, Dinjens WNM, Vecht CJ, Allgeier A, Lacombe D, Gorlia T, Hoang-Xuan K (2013): Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic olgodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol 31: 344–350PubMedGoogle Scholar
  19. van den Bent MJ, Carpentier AF, Brandes AA, Sanson M, Taphoorn MJB, Bernsen HJJA, Frenay M, Tijssen CC, Grisold W, Sipos L, Haaxma-Reich H, Kros JM, van Kouwenhoven MCM, Vecht CJ, Allgeier A, Lacombe D, Gorlia T (2006): Adjuvant procarbazine, lomustine, and vincristine improves progeression-free survival but not overall survival in newly diagnoses anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer Phase III Trial. J Clin Oncol 24: 27152–722Google Scholar
  20. Bentzen SM, Constine LS, Deasy JO et al. (2010) Quantitative Analyses of Normal Tissue Effects in the Clinic (Quantec): An Introduction to the Scientific Issues. Int. J. Radiation Oncology Biol. Phys., Vol. 76(3 Suppl):S3–S9Google Scholar
  21. Bessell EM, Graus F, Lopez-Guillermo A et al. (2001) CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 50:457–464PubMedGoogle Scholar
  22. Bessell EM, Lopez-Guillermo A, Villa S et al. (2002) Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments. J Clin Oncol 30:231–236Google Scholar
  23. Bhandare N, Jackson A, Eisbruch A et al. (2010) Radiation Therapy and Hearing Loss. Int. J. Radiation Oncology Biol. Phys., Vol. 76(3 Suppl):S50–S57Google Scholar
  24. Birnbaum T, Stadler EA, v Baumgarten L, Straube A (2012) Rituximab significantly improves complete response rate in patients with primary CNS lymphoma. J Neurooncol 109:285–291PubMedGoogle Scholar
  25. Bleyer WA, Griffin TW (1980) White matter necrosis mineralizing microangiopathy, and intellectual abilities in survivors of childhood leucemia; association with central nervous system irradiation and methotrexate. In: Gilbert HA, Kagan AR (eds) Radiation damage to the central nervous system. Raven, New York, pp 155–174Google Scholar
  26. Boardi A, Silvani A, Eoli M et al. (2000) Embryonal tumors in the adult population: implications in therapeutic planning. Neurol Sci 21:23–30Google Scholar
  27. Bondy M, Ligon BL (1996) Epidemiology and etiology of intracranial meningiomas: A review. J Neurooncol 29:197–205PubMedGoogle Scholar
  28. Bouffet E, Bernhard JL, Frappaz D et al. (1992) M4 protocol for cerebellar medulloblastoma: supratentorial radiotherapy may not be avoided. Int J Radiat Oncol Biol Phys 24:79–85PubMedGoogle Scholar
  29. Boyd TS, Mehta MP (1999) Stereotactic radiosurgery for brain metastases. Oncology 13:1397–1409PubMedGoogle Scholar
  30. Brandes AA, Ermani M, Amista P et al. (2003) The treatment of adults with medulloblastoma: A prospective study. Int J Radiat Oncol Biol Phys 57:755–761PubMedGoogle Scholar
  31. Brandes AA, Vastola F, Basso U et al. (2003) A retrospective study on glioblastoma in the elderly. Cancer 97:657–662PubMedGoogle Scholar
  32. Brem H, Piantadosi S, Burger PC et al. for the Polymer Brain Tumor Treatment Group (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345:1008–1012PubMedGoogle Scholar
  33. Broadbent AM, Hruby G, Tin MM, Jackson M, Firth I (2004) Survival following whole brain radiation treatment for cerebral metastases: an audit of 474 patients. Radioth Oncol 71:259–265Google Scholar
  34. Brown PD, Buckner JC, O’Fallon JF et al. (2003) Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein mini-mental state examination. J Clin Oncol 21:2519–2524PubMedGoogle Scholar
  35. Burger PC, Yu IT, Tihan T et al. (1998) Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. Am J Surg Pathol 22:1083–1092PubMedGoogle Scholar
  36. Caudell JJ, Ballo MT, Zagars GK et al. (2003) Radiotherapy in the management of giant cell tumor of bone. Int J Radiat Oncol Biol Phys 51:158–165Google Scholar
  37. Chamberlain MC (1992) Current concepts in leptomeningeal metastasis. Curr Op Oncol 4:533–539Google Scholar
  38. Chamberlain MC (2002) The role of stereotactically guided conformal radiotherapy for local tumor control of esthesioneuroblastoma. Cancer 95:243–248PubMedGoogle Scholar
  39. Chan AW, Tarbell JJ, Black PM et al. (2000) Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery 47:623–632PubMedGoogle Scholar
  40. Chang CH, Housepian EM, Herbert C (1969) An operative staging system and a mega voltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 93:1351–1359PubMedGoogle Scholar
  41. Chang SM, Lillis-Hearne PK, Larson DA et al. (1995) Pineoblastoma in Adults. Neurosurgery 37:383–391PubMedGoogle Scholar
  42. Chang SD, Adler JR Jr (1997) Treatment of cranial base meningiomas with linear accelerator radiosurgery. Neurosurgery 41(5):1019–1025, discussion 1025–1027PubMedGoogle Scholar
  43. Chang SD, Marcellus ML, Marks M et al. (2003) Multimodality treatment of giant intracranial arteriovenous malformations. Neurosurgery 53:1–11PubMedGoogle Scholar
  44. Capra M, Hargrave D, Bartels U et al. (2003) Central nervous system tumours in adolescents. Eur J Cancer 39:2643–2650PubMedGoogle Scholar
  45. Chuba PJ, Aronin P, Bhambhani K et al. (1997) Hyperbaric oxygen therapy for radiation-induced brain injury in children. Cancer 80:2005–2012PubMedGoogle Scholar
  46. Combs SE, Adeberg S, Dittmar JO et al. (2013) Skull base meningiomas: Long-term results and patients self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (IMRT). Radiother Oncol 106: 186–191PubMedGoogle Scholar
  47. Cox JD, Stanley K, Petrovich Z, Paig C, Yesner R (1981) Cranial irradiation in cancer of the lung of all cell types. JAMA 245:469–472PubMedGoogle Scholar
  48. Curran WJ, Scott CB, Horton J et al. (1993) Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704–710PubMedGoogle Scholar
  49. De Angelis LM, Delattre J, Posner J (1989) Radiation induced dementia in patients cured of brain metastases. Neurology 39:789–796Google Scholar
  50. De Angelis LM, Yahalom J, Thaler HA et al. (1992) Combined modality therapy for primary central nervous system lymphoma. J Clin Oncol 10:635–642Google Scholar
  51. De Angelis LM, Seiferheld W, Schold SC et al. (2002) Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol 20:4643–4648Google Scholar
  52. Debus J, Kocagoncu KO, Wenz F et al. (1998) Fractionated stereotactic radiotherapy (FSRT) for optic glioma. Int J Radiat Oncol Biol Phys 44:243–248Google Scholar
  53. Debus J, Schulz-Ertner D, Schad L et al. (2000) Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys 47(3): 591–596PubMedGoogle Scholar
  54. Debus J, Wuendrich M, Pirzkall A et al. (2001) High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J Clin Oncol 19(15): 3547–3557PubMedGoogle Scholar
  55. DeLaney TF, Liebisch NJ, Pedlow FX et al. (2009) Phase II study of high dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys 74: 732–739PubMedGoogle Scholar
  56. De Monte F, Smith HK, Al-Mefty O (1994) Outcome of aggressive removal of cavernous sinus meningiomas. J Neurosurg 81:245–251Google Scholar
  57. DeVile CJ, Grant DB, Hayward RD et al. (1996) Growth and endocrine sequelae of craniopharyngioma. Arch Dis Child 75 (2):108–114PubMedGoogle Scholar
  58. de Vos FY, Willemse PH, de Vries EG (2003) Successful treatment of metastatic esthesioneuroblastoma. Neth J Med 61:414–416PubMedGoogle Scholar
  59. Diener-West M, Dobbins TW, Phillips TL, Nelson DF (1989) Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int J Radiat Oncol Biol Phys 16:669–673PubMedGoogle Scholar
  60. Douglas JG, Barker JL, Ellenbogen RG, Geyer JR (2004) Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure. Int J Radiat Oncol Biol Phys 58:1161–1164PubMedGoogle Scholar
  61. Emami B, Lyman J, Brown A et al. (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109–122PubMedGoogle Scholar
  62. Engenhart R, Kimmig BN, Hover K, Wowra B, Romahn J, Lorenz WJ (1993) Long-term follow-up for brain metastases treated by percutaneus single high-dose radiation. Cancer 71:1353–1361PubMedGoogle Scholar
  63. Engenhart R, Wowra B, Debus J et al. (1994) The role of high-dose single-fraction irradiation in small and large intracranial arteriovenous malformations. Int J Radiat Oncol Biol Phys 30:521–529PubMedGoogle Scholar
  64. Engenhart-Cabillic R, Debus J (1998) Linear accelerator radiosurgery for arterio-venous malformations: The relationship of size, dose, time, and planning factors onto outcome. In: Hellwig D, Bauer BL (eds) Minimally invasive techniques for neurosurgery. Springer, Berlin Heidelberg New York Tokio, pp 145–150Google Scholar
  65. Engenhart-Cabillic R, Kocher M, Müller R-P (1999) Leitlinien zur Strahlentherapie von Hypophysenadenomen, hrsg. von AG Hypophyse und Hypophysentumoren der Deutschen Gesellschaft für Endokrinologie (DGE), der Deutschen Gesellschaft für Radioonkologie (DEGRO), der Deutschen Gesellschaft für Neurochirurgie, AG für Radioonkologie (ARO) und Neuroonkologie (NAO) der Deutschen Krebsgesellschaft. Dt Medizinische Wochenschrift 124:1148–1152Google Scholar
  66. EORTC/RTOG late effects working group (1995) LENT SOMA tables: table of contents. Radiother Oncol 35:17–60Google Scholar
  67. Epstein BE, Scott CB, Sause WT et al. (1993) Improved survival duration in patients with unresected solitary brain metastases using accelerated hyperfractionated radiation therapy at total doses of 54.5 gray and greater: results of radiation oncology group 85-28. Cancer 71:1362–1367PubMedGoogle Scholar
  68. Eustacchio S, Trummer M, Fuchs I, Schrottner O, Sutter B, Pendl G (2002) Preservation of cranial nerve function following Gamma Knife radiosurgery for benign skull base meningiomas: experience in 121 patients with follow-up of 5 to 9,8 years. Acta Neurochir (Suppl) 84:71–76Google Scholar
  69. Evans RG, Nesbit ME, Gehan EA et al. (1991) Multimodal therapy for the management of localized Ewing’s sarcoma of pelvic and sacral bones: a report from the second intergroup study. J Clin Oncol 9:1173–1180PubMedGoogle Scholar
  70. Fahlbusch R, Honegger J, Paulus W et al. (1999) Surgical treatment of craniopharyngeomas: Experience with 168 patients. J Neurosurg 90:237–250PubMedGoogle Scholar
  71. Fairchild A, Weber DC, Bar-Deroma R, Gulyban A, Fenton PA, Stupp R, Baumert BG (2012) Quality assurance in the EORTC 22033-26033/CE5 phase III randomized trial for low grade glioma. The digital individual case review. Radiother Oncol 103: 287–292PubMedGoogle Scholar
  72. Fajardo LF (1992) Morphology of radiation effects on normal tissue. In: Perez CA, Brady LW (eds) Principles and practice of radiation oncology, 2nd ed. Lippincott, Philadelphia New York London Hagerstown, pp 114–123Google Scholar
  73. Fine H, Dear KBG, Loeffler JS et al. (1993) Meta Analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71:2587–2597Google Scholar
  74. Flickinger JC, Kondziolka D, Lunsford LD et al. (1994) A multiinstitutional experience with stereotactic radiosurgery for solitary brain metastases. Int J Radiat Oncol Biol Phys 28:797–802PubMedGoogle Scholar
  75. Flickinger JC, Kondziolka D, Lunsford LD (1996) Dose and diameter relationships for facial, trigeminal, and acoustic neuropathies following acoustic neuroma radiosurgery. Radiother Oncol 41:215–219PubMedGoogle Scholar
  76. Flickinger JC, Kondziolka D, Niranjan A, Voynov G, Maitz A, Lunsford LD (2003) Acoustic neuroma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys 57:S325Google Scholar
  77. Fokas E (2013) Stereotactic Radiosurgery of Cerebral Arteriovenous Malformations: Long-Term Follow-up in 164 Patients of a Single Institution. Journal of NeurologyGoogle Scholar
  78. Foote KD, Friedman WA, Ellis TL et al. (2003) Salvage retreatment after failure of radiosurgery in patients with arteriovenous malformations. J Neurosurg 98:337–341PubMedGoogle Scholar
  79. Friedman WA, Bova FJ, Bollampally S et al. (2003) Analysis of factors predictive of success or complications in arteriovenous malformation radiosurgery. Neurosurgery 52:296–308PubMedGoogle Scholar
  80. Frost PJ, Laperriere NJ, Wong CS et al. (1995) Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 32:1255–1257Google Scholar
  81. Fuss M, Debus J, Lohr F, Huber P, Rhein B, Engenhart-Cabillic R, Wannenmacher M (2000) Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas. Int J Radiat Oncol Biol Phys 48(5):1381–1387PubMedGoogle Scholar
  82. Gambardella G, Gervasio O, Zaccone C (2003) Approaches and surgical results in the treatment of ventral thoracic meningiomas. Review of our experience with a postero-lateral combined transpedicular-transarticular approach. Acta Neurochir (Wien) 145:385–392Google Scholar
  83. Gardner G, Robertson JH (1988) Hearing preservation in unilateral acoustic tumor surgery. Ann Otol Rhinol Laryngol 97:55–66PubMedGoogle Scholar
  84. Gaspar L, Scott C, Rotman M et al. (1997) Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751PubMedGoogle Scholar
  85. Glantz MJ, Cole BG, Forsyth PA et al. (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54(10):1886–1893PubMedGoogle Scholar
  86. Glantz M, Chamberlain M, Liu Q, Litofsky NS, Recht LD (2003) Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. Cancer 97:2262–2266PubMedGoogle Scholar
  87. Glioma Meta-analysis Trialists (GMT) Group (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 359:1011–1018Google Scholar
  88. Gnekow AK, Kaarsch P, Kortmann R et al. (2000) HIT-LGG: effectiveness of carboplatin-vincristine in progressive lowgrade gliomas of childhood – an interim report. Klin Pädiatr 212:177–184Google Scholar
  89. Göbel U, Schneider DT, Calaminus G, Haas RJ, Schmidt P, Harms D (2000) Germ cell tumors in childhood and adolescence. Annals of Oncology 11:263–271PubMedGoogle Scholar
  90. Götz I, Spehl TS, Weber WA, Grosu AL (2012) PET and SPECT for radiation treatment planning. Q J Nucl Med Mol Imaging 56: 163–172PubMedGoogle Scholar
  91. Gonzales DG, Menten J, Bosch DA et al. (1994) Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study. Radiother Oncol 32:98–105Google Scholar
  92. Gordon KB, Char DH, Sagerman RH (1995) Late effects of radiation on the eye and ocular adnexa. Int J Radiat Oncol Biol Phys 31:1123–1139PubMedGoogle Scholar
  93. Gore EM, Bae K, Wong SJ et al. (2011) Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. J Clin Oncol. 29 (3): 272–278. Erratum in: J Clin Oncol. 2011: 29 (23):3204Google Scholar
  94. Gross MW, Spahn U, Engenhart-Cabillic R (2003) Assessment of the accuracy of a conventional simulation for radiotherapy of head and skull base tumours. Technol Cancer Res Treat 2:345–351PubMedGoogle Scholar
  95. Grosu AL, Kocher M, Voges J et al. (2000) Radiotherapy of pituitari tumors: In: Petrovitch Z, Brady LW, Apuzzo ML, Bamberg M (eds) Combined modality therapy of central nervous system tumors. Springer, Berlin, pp 167–182Google Scholar
  96. Grosu AL, Feldmann H, Dick S et al. (2002) Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas. Int J Radiat Oncol Biol Phys 54:842–854PubMedGoogle Scholar
  97. Grosu AL, Weber AW, Riedel E et al. (2005) L-(Methyl-11c) methionine positron emission tomography for target delineation in resected high grade gliomas before radiation therapy. Int J Rad Oncol Biol Phys 63: 64–74Google Scholar
  98. Grüschow K, Klautke G, Fietkau R (2002) Phase I/II clinical trial of concurrent radiochemotherapy in combination with topotecan for the treatment of brain metastases. Eur J Cancer 38:367–374PubMedGoogle Scholar
  99. Habrand JL, Ganry O, Couanet D et al. (1999) The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int J Radiat Oncol Biol Phys 44:255–263PubMedGoogle Scholar
  100. Habrand JL, de Crevoisier R (2001) Radiation therapy in the management of childhood brain tumors. Child Nerv Syst 17:121–133Google Scholar
  101. Hakim R, Zervas NT, Hakim F et al. (1997) Initial characterization of the dosimetry and radiology of a device for administering interstitial stereotactic radiosurgery. Neurosurgery 40(3):510–516PubMedGoogle Scholar
  102. Hakim R, Alexander E 3rd, Loeffler JS et al. (1998) Results of linear accelerator-based radiosurgery for intracranial meningiomas. Neurosurgery 42(3):446–454PubMedGoogle Scholar
  103. Hansen SB, Galsgard H, von Eyben FE, Westergaard-Nielsen V, Wolf-Jensen J (1986) Tamoxifen for brain metastases from breast cancer. Ann Neurol 20:544–545PubMedGoogle Scholar
  104. Harsh GR, Levin VA, Gutin PH et al. (1987) Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 21:615–621PubMedGoogle Scholar
  105. Hegi ME, Diserens AC, Gorlia T et al (2005): MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352: 997–1003PubMedGoogle Scholar
  106. Henzel G, Gross MW, Hammer K et al. (2006) Stereotactic radiotherapy of meningiomas: symptomatology, acute and late toxicity. Strahlenther Onkol 2006; 182: 382–388PubMedGoogle Scholar
  107. Henzel M, Gross M, Hamm K et al. Stereotactic radiotherapy of cavernous sinus invading meningiomas: symptomatology, acute and late toxicity. J Clin Oncol submittedGoogle Scholar
  108. Herrlinger U, Felsberg J, Küker W et al. (2002) Gliomatosis cerebri: molecular pathology and clinical course. Ann Neurol 52:390–399PubMedGoogle Scholar
  109. Herrlinger U, Schabet M, Brugger W et al. (2002) German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma. Ann Neurol 51:247–252PubMedGoogle Scholar
  110. Heyd R, Seegenschmiedt MH, Rades D et al. (2010) The significance of radiation therapy for symptomatic vertebral hemangiomas (SVH). Strahlenther Onkol 186: 430–435PubMedGoogle Scholar
  111. Hilden JM, Watterson J, Longee DC et al. (1998) Central nervous system atypical teratoid tumor/rhabdoid tumor: Response to intensive therapy and review of the literature. J Neurooncol 40:265–275PubMedGoogle Scholar
  112. Ho DMT, Hsu CY, Wong TT et al. (2000) Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma. Acta Neuropathol 99:482–488PubMedGoogle Scholar
  113. Hochberg FH, Pruitt A (1980) Assumptions in the radiotherapy of glioblastoma. Neurology 30:907–911PubMedGoogle Scholar
  114. Höcht S, Wiegel T, Hinkelbein W (1999) Reirradiation for recurrent brain metastases: an overview. In: Wiegel T, Hinkelbein W, Brock M, Hoell T (eds) Frontiers of radiation therapy and oncology, 33. Karger, Basel, pp 327–331Google Scholar
  115. House JW, Brackmann DE (1985) Facial nerve grading system. Otolaryngol Head Neck Surg 93:146–147PubMedGoogle Scholar
  116. Hug EB, Fitzek MM, Liebsch NJ et al. (1995) Locally challenging osteo- and chondrogenic tumors of the axial skeleton: results of combined proton and photon radiation therapy using three-dimensional treatment planning. Int J Radiat Oncol Biol Phys 31:467–476PubMedGoogle Scholar
  117. Huh SK, Lee KC, Lee KS et al. (2000) Selection of treatment modalities for cerebral arteriovenous malformations: a retrospective analysis of 348 consecutive cases. J Clin Neurosci 7:429–433PubMedGoogle Scholar
  118. Hussain A, Brown PD, Stafford SL, Pollock BE (2007) Stereotactic radiosurgery for brainstem metastases: Survival, tumor control, and patient outcomes. Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):521–524PubMedGoogle Scholar
  119. Isaacson SR (2000) Radiation therapy and the management of intramedullary spinal cord tumors. J Neuro-Oncol 47: 231–238Google Scholar
  120. Jääskeläinen J, Servo A, Haltia M et al. (1992) Meningeal hemangiopericytoma. In: Schmidek HH (ed) Meningeomas and their surgical management. WB Saunders, PhiladelphiaGoogle Scholar
  121. Jahnke K, Korfel A, Martus P, et al. (2005) High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma. Ann Oncol 16:445–449PubMedGoogle Scholar
  122. Jalali R, Loughrey C, Baumert B et al. (2002) High precision focused irradiation in the form of fractionated stereotactic conformal radiotherapy (SCRT) for benign meningiomas predominantly in the skull base location. Clin Oncol (R Coll Radiol) 14(2):103–109Google Scholar
  123. Johannesen TB, Langmark F, Lote K (2003) Cause of death and long-term survival in patients with neuro-epithelial brain tumours: a population-based study. Eur J Cancer 39: 2355–2363PubMedGoogle Scholar
  124. Kapelle AC, Postma TJ, Taphoorn MJ et al. (2001) PCV chemotherapy for recurrent glioblastoma multiforme. Neurology 56:118–120Google Scholar
  125. Karger CP, Hartmann GH, Peschke P et al. (1997) Dose-response relationship for late functional changes in the rat brain after radiosurgery evaluated by magnetic resonance imaging. Int J Radiat Oncol Biol Phys 39:1163–1172PubMedGoogle Scholar
  126. Karim ABB, Maat B, Hatlevoll R et al. (1996) A randomized trial on dose response in radiation therapy of low-grade cerebral glioma. Int J Rad Oncol Biol Phys 36:636–641Google Scholar
  127. Karim AB, Afra D, Cornu P et al. (2002) Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 52:316–324PubMedGoogle Scholar
  128. Karpinos M, Teh BS, Zeck O et al. (2002) Treatment of acoustic neuroma: stereotactic radiosurgery vs. microsurgery. Int J Radiat Oncol Biol Phys 54(5):1410–1421PubMedGoogle Scholar
  129. Kasenda B, Schorb E, Fritsch K et al. (2012) Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma - a long-term follow-up study. Annals of Oncology 23:2670–2675PubMedGoogle Scholar
  130. Keime-Guilbert F, Chinot O, Taillandier L, et al. (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356: 1527–1537Google Scholar
  131. Keisch ME, Garcia DM, Shibuya RB (1991) Retrospective long-term follow-up analysis in 21 patients with chordomas of various sites treated at a single institution. J Neurosurg 75:374–377PubMedGoogle Scholar
  132. Kim YS, Kondziolka D, Flickinger JC, Lunsford LD (1997) Stereotactic radiosurgery for patients with nonsmall cell lung carcinoma metastatic to the brain. Cancer 80:2075–2083PubMedGoogle Scholar
  133. Kim JW, Kim WC, Cho JH, et al. (2012) A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors. Int J Radiat Oncol Biol Phys 84(3): 625–631PubMedGoogle Scholar
  134. Kleihues P, Cacenee WK (1998) World Health Organization classification of tumours. Pathology genetics. Tumours of the nervous system. IARC Press, LyonGoogle Scholar
  135. Klekamp J, Samii M (1998) Surgery of spinal nerve sheath tumors with special reference to neurofibromatosis. Neurosurgery 42:279–289PubMedGoogle Scholar
  136. Kocher M, Wilms M, Makoski HB et al. (2004) Alpha/beta ratio for arteriovenous malformations estimated from obliteration rates after fractionated and single-dose irradiation. Radiother Oncol 71:109–114PubMedGoogle Scholar
  137. Kocher M, Soffietti R, Abacioglu U et al. (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001.. J Clin Oncol 29:134–141.PubMedGoogle Scholar
  138. Komarnicky LT, Phillips TL, Martz K, Asbell S, Isaacson S, Urtasun R (1991) A randomized Phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG 7916). Int J Radiat Oncol Biol Phys 20:53–58PubMedGoogle Scholar
  139. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC (1999) Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45:427–434PubMedGoogle Scholar
  140. Kortmann RD, Hess CF, Hoffmann E et al. (1995) Is the standardized helmet technique adequate for irradiation of the brain and the cranial meninges? Int J Radiat Oncol Biol Phys 45:241–244Google Scholar
  141. Kortmann RD, Bogdahn U, Westphal M et al. (2003) Medulloblastome im Erwachsenenalter. Onkologe 9:710–720Google Scholar
  142. Koswig S, Budach V (1999) Remineralization and pain relief in bone metastses after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study. Strahlenther Onkol 175: 500–508PubMedGoogle Scholar
  143. Kreth FW, Faist M, Rossner R et al. (1997) The risk of interstitial radiotherapy of low-grade gliomas. Radiother Oncol 43:253–260PubMedGoogle Scholar
  144. Kreth FW, Berlis A, Spiropoulou V et al. (1999) The role of tumor resection in the treatment of glioblastoma multiforme in adults. Cancer 86:2117–2123PubMedGoogle Scholar
  145. Lacaze E, Kieffer V, Streri A et al. (2003) Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy. Br J Cancer 89:2038–2044PubMedGoogle Scholar
  146. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI (1999) Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 43:795–803PubMedGoogle Scholar
  147. Laperriere NJ, Leung PMK, McKenzie S et al. (1998) Randomized study of brachytherapy in the initital management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 41:1005–1011PubMedGoogle Scholar
  148. Lawrence YR, Li XA, el Naqa I et al. (2010) Radiation Dose-Volume Effects in the Brain. Int. J. Radiation Oncology Biol. Phys., Vol. 76(3 Suppl):S20–S27Google Scholar
  149. Leber KA, Berglöff J, Langmann G et al. (1995) Radiation sensitivity of visual and oculomotor pathways. Stereotact Funct Neurosurg 64 (Suppl):233–238PubMedGoogle Scholar
  150. Lee JS, Murphy WK, Glisson BS, Dhingra HM, Holoye PY, Hong WK (1989) Primary chemotherapy of brain metastasis in small-cell lung cancer. J Clin Oncol 7:916–922PubMedGoogle Scholar
  151. Lee JY, Niranjan A, McInerney J et al. (2002) Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. J Neurosurg 97(1):65–72PubMedGoogle Scholar
  152. Le Péchoux C, Dunant A, Senan S, Wolfson A, Quoix E, Faivre-Finn C, Ciuleanu T, Arriagada R, Jones R, Wanders R, Lerouge D, Laplanche (2009) A: Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. Lancet Oncol 10(5):467–74Google Scholar
  153. Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, Wilson CB (1990) Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PVC) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18:321–324PubMedGoogle Scholar
  154. Li MH, Holtas S (1991) MR imaging of spinal intramedullary tumors. Acta Radiol 32:505–513PubMedGoogle Scholar
  155. Li MH, Holtas S, Larsson EM (1992) MR imaging of intradural extramedullary tumors. Acta Radiol 33:207–212PubMedGoogle Scholar
  156. Linskey ME, Lunsford LD, Flickinger JC (1992) Tumor control after stereotactic radiosurgery in neurofibromatosis patients with bilateral acoustic tumors. Neurosurgery 31:829–839PubMedGoogle Scholar
  157. Linskey ME, Flickinger JJC, Lunsford LC (1993) Cranial nerve length predicts the risk of delayed facial and trigeminal neuropathies after acoustic tumor stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 25:227–233PubMedGoogle Scholar
  158. Linstadt DE (2004) Spinal cord tumors. In: Leibel SA, Phillips TL (eds) Textbook of radiation oncology. Saunders, Philadelphia, pp 565–578Google Scholar
  159. Liscak R, Simonova G, Vymazal J et al. (1999) Gamma knife radiosurgery of meningiomas in the cavernous sinus region. Acta Neurochir 141(5):473–480PubMedGoogle Scholar
  160. Lodin K, Dattoli M, Milcu M (1990) Radiation therapy for adult spinal cord ependymomas: the case for limited volume treatment. Proceedings from the 72nd Annual American Radium Society MeetingGoogle Scholar
  161. Lonser RR, Weil RJ, Wanebo JE et al. (2003) Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 98:106–116PubMedGoogle Scholar
  162. Louis DN, Ohgaki H, Wiestler OD et al. (2007) WHO classification of tumours of the central nervous system. Lyon: IARCGoogle Scholar
  163. Lutterbach J, Fauchon F, Schild SE et al. (2002) Malignant pineal parenchymal tumors in adult patients: patterns of care and prognostic factors. Neurosurgery 51:44–55PubMedGoogle Scholar
  164. Maier H, Ofner D, Hirrmair A et al. (1992) Classic, atypical, and anaplastic menigeoma: Three histopathological subtypes of clinical relevance. J Neurosurg 77:616–623PubMedGoogle Scholar
  165. Malmström A, Gronberg BH, Marosi C, Stupp R, Frappaz D, Schultz H, Abacioglu U, Tavelin B, Lhermittre B, Hegi ME, Rosell J, Henriksson R (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol 13: 916–926PubMedGoogle Scholar
  166. Matsutani M, Sano K, Takakura K, et al. (1997) Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg 86: 4446–455Google Scholar
  167. Matsuo T, Shibata S, Yasunaga A et al. (1999) Dose optimization and indication of linac radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 45:931–939PubMedGoogle Scholar
  168. Mayo C, Yorke E, Merchant TE (2010a) Radiation associated Brainstem Injury. Int. J. Radiation Oncology Biol. Phys., Vol. 76(3 Suppl):S36–41Google Scholar
  169. Mayo C, Martel MK, Marks LB (2010b) Radiation Dose-Volume Effects of Optic Nerves and Chiasm. Int. J. Radiation Oncology Biol. Phys., Vol. 76(3 Suppl):S28–35Google Scholar
  170. Mazloom A, Wolff JE, Paulino AC. (2010) The impact of radiotherapy field in the treatment of patients with choroid plexus carcinoma. In tJ Radiat Oncol Biol Phys 78(1): 79–85Google Scholar
  171. Medical Research Council Brain Tumour Working Party (2001) Randomized trial ob procarbazine, lomustine and vincristine in the adjuvant treatment of high-grade astrocytoma: A Medical Research Council Trial. J Clin Oncol 19:509–518Google Scholar
  172. Meeks SL, Buatti JM, Foote KD et al. (2000) Calculation of cranial nerve complication probability for acoustic neuroma radiosurgery. Int J Radiat Oncol Biol Phys 47:597–602PubMedGoogle Scholar
  173. Meijer OW, Vandertop WP, Baayen JC, Slotman BJ (2003) Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: a single-institution study. Int J Radiat Oncol Biol Phys 56(5):1390–1396PubMedGoogle Scholar
  174. Mendenhall WM, Friedman WA, Buatti JM et al. (1996) Preliminary results of linear accelerator radiosurgery for acoustic schwannomas. J Neurosurg 85:1013–1019PubMedGoogle Scholar
  175. Merchant TE, Wang MH, Haida T et al. (1996) Medulloblastoma: Long-term results for patients treated with definitive radiation therapy during the computed tomography era. Int J Radiat Oncol Biol Phys 36:29–35PubMedGoogle Scholar
  176. Merchant TE, Gould CJ, Xiong X et al. (2004) Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors. Int J Radiat Oncol Biol Phys 58:1194–1207PubMedGoogle Scholar
  177. Milker-Zabel S, Debus J, Thilmann C, Schlegel W, Wannenmacher M (2001) Fractionated stereotactically-guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland. Int J Radiat Oncol Biol Phys 50(5):1279–1286PubMedGoogle Scholar
  178. Milker-Zabel S, Zabel A, Huber P, Schlegel W, Wannenmacher M, Debus J (2003) Stereotactic conformal radiotherapy in patients with growth-hormone secreting pituitary adenoma. Int J Radiat Oncol Biol Phys 59(4):1088–1096Google Scholar
  179. Milker-Zabel S, Zabel-du Bois A, Huber P, Schlegel W, Debus J (2006) Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas: long-term experience and review of the literature. Strahlenther Onkol 182: 635–640PubMedGoogle Scholar
  180. Miller PJ, Hassanein RS, Shankar PG (1990) Univariate and multivariate statistical analysis of high-grade gliomas: The relationship of radiation dose and other prognostic factors. Int J Radiat Oncol Biol Phys 19:275–280PubMedGoogle Scholar
  181. Miller RC, Foote RL, Coffey RJ, Sargent DJ, Gorman DA, Schomberg PJ, Kline RW (1999) Decrease in cranial nerve complications after radiosurgery for acoustic neuromas: a prospective study of dose and volume. Int J Radiat Oncol Biol Phys 43(2):305–311PubMedGoogle Scholar
  182. Mintz AH, Kestle J, Rathbone MP, Gaspar L, Hugenholtz H, Fischer B (1996) A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastases. Cancer 78:1470–1476PubMedGoogle Scholar
  183. Mira J, Miller T, Crowley J (1990) Chest irradiation (RT) vs. chest RT + chemotherapy +/-prophylactic brain RT in localized non-small cell lung cancer: A Southwest Oncology Group randomized study. Int J Radiat Oncol Biol Phys 19(S1):145Google Scholar
  184. Mitsumori M, Shrieve DC, Alexander E 3rd et al. (1998) Initial clinical results of linac-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 42:573–580PubMedGoogle Scholar
  185. Mohan DS, Suh JH, Phan JL, Kupelian PA, Cohen BH, Barnett GH (1998) Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys 42(5):981–987PubMedGoogle Scholar
  186. MRC Brain Tumor Working Party (1990) Prognostic factors for high grade malignant glioma: development of a prognostic index. J Neurooncol 9:47–55Google Scholar
  187. MRC Brain Tumor Working Party (1991) A medical research council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. Br J Cancer 64:769–774Google Scholar
  188. Mulhern RK, Palmer SL, Reddick WE et al. (2001) Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J Clin Oncol 19:472–479PubMedGoogle Scholar
  189. Munzenrider JE, Liebsch NJ (1999) Proton therapy for tumors of the skull base. Strahlenther Oncol 175 (Suppl 2):57–63Google Scholar
  190. Nakata H, Yoshimine T, Murasawa A et al. (1995) Early bloodbrain barrier disruption after high-dose single-fraction irradiation in rats. Acta Neurochir Wien 136:82–86PubMedGoogle Scholar
  191. Neriishi K, Nakashima E, Akahoshi M et al. (2012) Radiation close and cataract surgery incidence in atomic bomb survivors., 1986-2005. Radiology 265: 167–174PubMedGoogle Scholar
  192. Nicolato A, Foroni R, Alessandrini F et al. (2002) The role of gamma knife radiosurgery in the management of cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys 53(4):992–1000PubMedGoogle Scholar
  193. Nieder C, Nestle U, Walter K, Niewald M, Schnabel K (1998) Dose/effect realationships for brain metastases. J Cancer Res Clin Oncol 124:346–350PubMedGoogle Scholar
  194. NOA-01 Working Group (2003) Neuro-Oncology Working Group 01: Trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involvedfield radiotherapy in the first-line treatment of malignant glioma. J Clin Oncol 21:3276–3284Google Scholar
  195. Noordijk EM, Vecht CJ, Haaxma-Reiche H et al. (1994) The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 29:711–717PubMedGoogle Scholar
  196. Ogilvy CS, Stieg PE, Awad I et al. (2001) Recommendations for the management of intracranial arteriovenous malformations. A statement for healthcare professionals from a special writing group of the stroke council, american stroke association. Stroke 32:1458–1471PubMedGoogle Scholar
  197. Packer RJ, Zhou T, Holmes E, Vezina G, Gajjar A (2013) Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children’s Oncology Group trial A9961. Neuro Ocol 15: 97–103Google Scholar
  198. Palmer SL, Goloubeva O, Reddick WE et al. (2001) Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis. J Clin Oncol 19:2302–2308PubMedGoogle Scholar
  199. Patchell RA, Tibbs PA, Walsh JW et al. (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494–500PubMedGoogle Scholar
  200. Patchell RA, Tibbs PA, Regine WF et al. (1998) Postoperative radiotherapy in the treatment of single brain metastases to the brain: a randomized trial. JAMA 280:1485–1489PubMedGoogle Scholar
  201. Patchell R, Tibbs PA, Regine WF et al. (2003) A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Proc Am Soc Oncol 22:1Google Scholar
  202. Paulino AC, Cha DT, Barker JL et al. (2004) Patterns of failure in relation to radiotherapy fields in supratentorial primitive neuroectodermal tumor. Int J Radiat Oncol Biol Phys 58:1171–1176PubMedGoogle Scholar
  203. Pels H, Schmidt-Wolf IGH, Glasmacher A et al. (2003) Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy. J Clin Oncol 21:4489–4495PubMedGoogle Scholar
  204. Phillips C, Guiney M, Smith J, Hughes P, Narayan K, Quong G (2003) A randomized trial comparing 35 Gy in ten fractions with 60 Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma. Radiother Oncol 68(1):23–26PubMedGoogle Scholar
  205. Pikus HJ, Beach ML, Harbaugh RE (1998) Microsurgical treatment of arteriovenous malformations: analysis and comparison with stereotactic radiosurgery. J Neurosurg 88:641–646PubMedGoogle Scholar
  206. Pirzkall A, Debus J, Lohr F, Fuss M, Rhein B, Engenhart-Cabillic R, Wannenmacher M (1998) Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 16:3563–3569PubMedGoogle Scholar
  207. Pistolesi S, Boldrini L, Gisfredi S et al. (2004) Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study. Neuropathol Appl Neurobiol 30(2):118–125PubMedGoogle Scholar
  208. Plathow C, Schulz-Ertner D, Thilman C et al. (2003) Fractionated stereotactic radiotherapy in low-grade astrocytomas: Long-term outcome and prognostic factors. Int J Radiat Oncol Biol Phys 57:996–1003PubMedGoogle Scholar
  209. Pöttgen C, Eberhardt W, Grannass A, Korfee S, Stüben G, Teschler H, Stamatis G, Wagner H, Passlick B, Petersen V, Budach V, Wilhelm H, Wanke I, Hirche H (2007) Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial. Clin Oncol. 25(31):4987–4992Google Scholar
  210. Pollock BE, Lunsford LD, Kondziolka D et al. (1994) Patient outcomes after stereotactic radiosurgery for “operable” arteriovenous malformations. Neurosurgery 35:1–7PubMedGoogle Scholar
  211. Pollock BE, Stafford SL, Link MJ (2000) Gamma knife radiosurgery for skull base meningiomas. Neurosurg Clin N Am 11(4):659–666PubMedGoogle Scholar
  212. Posner JB (1990) Surgery for metastases to the brain. New Engl J Med 322:544–545PubMedGoogle Scholar
  213. Prados MD, Scott C, Curran WJ Jr, Nelson DF, Leibel S, Kramer S (1999) Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: a retrospective review of Radiation Therapy Oncology Group protocols comparing survival with carmustine or PCV adjuvant chemotherapy. J Clin Oncol 17:3389–3395PubMedGoogle Scholar
  214. Prasat D, Steiner M, Steiner L (2000) Gamma surgery for vestibular schwannoma. J Neurosurg 92:745–749Google Scholar
  215. Radbill AE, Fiveash JF, Falkenberg ET, Guthrie BL, Young PE, Meleth S, Markert JM (2004) Initial treatment of melanoma brain metastases using gamma knife radiosurgery. An evaluation of efficacy and toxicity. Cancer 101:825–833PubMedGoogle Scholar
  216. Rades D, Bajrovic A, Alberti W et al. (2003) Is there a dose effect relationship for the treatment of symptomatic vertebral hemangioma? Int J Radiat Oncol Biol Phys 55:178–181PubMedGoogle Scholar
  217. Rades D, Douglas S, Veninga T et al. (2010b) Validation and simplification of a score predicting durvival in patients irradiated for metastatic spinal cord compression. Cancer 116: 3670–3673Google Scholar
  218. Rades D, Dunst J, Schild SE (2008) The first score predicting overall survival in patients with metastatic spinal and compression. Cancer 112: 157–161PubMedGoogle Scholar
  219. Rades D, Heidenreich F, Karstens JH (2002) Final results of a prospective study of the prognostic value of the time to develop motor deficits before irradiation in metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 53:975–979PubMedGoogle Scholar
  220. Rades D, Huttenlocher S, Dunst J (2010a) A matched pair analysis comparing surgery followed by radiotherapy to radiotherapy alone for metastatic spinal cord compression (MSCC). J Clin Oncol 28: 3597–3604Google Scholar
  221. Rades D, Karstens JH, Alberti W (2002) The role of radiotherapy in the treatment of motor dysfunction due to metastatic spinal cord compression: a comparison of three different fractionation schedules. Int J Radiat Oncol Biol Phys 54:1160–1164PubMedGoogle Scholar
  222. Rades D, Lange M, Veninga T et al. (2009) Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long course radiotherapy for local control of malignant epidural spinal cord compression. Int J Radiat Oncol Biol Phys 73: 228–234PubMedGoogle Scholar
  223. Rades D, Schild SE, Tatagiba M et al. (2004) Therapy of meningeal melanocytomas. Cancer 100:2442–2447PubMedGoogle Scholar
  224. Rades D, Schild SE (2006) Dose-responses relationship for fractionated irradiation in the treatment of spinal meningeal melanocytomas: a review of the literature. J Neurooncol 77: 311–314PubMedGoogle Scholar
  225. Rades D. Stalpers LJA, Veninga T et al. (2005) Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression in a series of 1304 patients. J Clin Oncol 23: 3366–3375PubMedGoogle Scholar
  226. Rades D, Huttenlocher S, Bajrovic A et al. (2011) Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. Int J Radiat Oncol Biol Phys 81: e 861–868Google Scholar
  227. Rajan B, Ashley S, Gorman C et al. (1993) Craniopharyngioma – long-term results following limited surgery and radiotherapy. Radiother Oncol 26:1–10PubMedGoogle Scholar
  228. Regine WC, Mohiuddin M, Kramer S (1993) Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation. Radiother Oncol 27:13–21PubMedGoogle Scholar
  229. Reifenberger G, Louis DN (2003) Oligodendroglioma: Toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 62:111–126PubMedGoogle Scholar
  230. Rich TA, Schiller A, Suit HD et al. (1985) Clinical and pathologic review of 48 cases of chordomas Cancer 56:182–187PubMedGoogle Scholar
  231. Ris MD, Packer R, Goldwein J (2001) Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children’s Cancer Group Study. J Clin Oncol 19:3470–3476PubMedGoogle Scholar
  232. Roa W, Brasher PM, Bauman G et al. (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22:1540–1541Google Scholar
  233. Romero J, Cardenes H, La Torre A et al. (1993) Chordoma: results of radiation therapy in eighteen patients. Radiother Oncol 29:27–32PubMedGoogle Scholar
  234. Rudoler SB, Corn BW, Shields CL (1997) External beam irradiation for choroid metastases: Identification of factors predisposing to long-term sequelae. Int J Radiat Oncol Biol Phys 38:251–256PubMedGoogle Scholar
  235. Russell AH, Pajak TE, Selim H (1991) Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastases: Results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 21:637–643PubMedGoogle Scholar
  236. Rutz HP, Weber DC, Goitein G et al. (2008) Postoperative spot-scanning proton radiation therapy for chordoma and chondrosarcoma in children and adolescents: initial experience at paul scherrer intitute. Int J Radiat Oncol Biol Phys 71:220–225PubMedGoogle Scholar
  237. Ryu S, Kim DH, Chang SD (2003) Stereotactic radiosurgery for hemangiomas and ependymomas of the spinal cord. Neurosurg Focus 15: E10Google Scholar
  238. Salazar OM, Castro-Vita H, van Houtte P et al. (1983) Improved survival in cases of intracranial ependymoma after radiation therapy: late report and recommendations. J Neurosurg 59:652–659PubMedGoogle Scholar
  239. Samii M, Tatagiba M (1995) Craniopharyngeoma. In: Kaye AH, Laws ER Jr (eds) Brain tumors. Churchill Livingstone Inc., New York, pp 873–894Google Scholar
  240. Samii M, Matthies C (1997) Management of 1000 vestibula: schwannomas (acoustic neuromas): Surgical management and results with an emphasis on complication and how to avoid them. Neurosurg 40:11–23Google Scholar
  241. Sanford RA (1994) Craniopharyngioma: Results of survey of the American Society of Pediatric Neurosurgery. Pediatr Neurosurg 21 (Suppl 1):39–43PubMedGoogle Scholar
  242. Schlechte JA (2003) Prolactinoma. N Engl J Med 349:2035–2041PubMedGoogle Scholar
  243. Schlegel W, Mahr A (2001) 3D-conformal radiation therapy – multimedia introduction to methods and technology. CD-ROM. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  244. Schulz-Ertner D, Frank C, Herfarth KK et al. (2002) Fractionated stereotactic radiotherapy for craniopharyngiomas. Int J Radiat Oncol Biol Phys 54(4):1114–1120PubMedGoogle Scholar
  245. Schulz-Ertner D, Nikoghosyan A, Thilmann C et al. (2003) Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Strahlenther Onkol 179: 598–605PubMedGoogle Scholar
  246. Seegenschmiedt MH, Sauer R (1993) Systematik der akuten und chronischen Strahlenfolgen. Strahlenther Onkol 83: 83–95Google Scholar
  247. Selker RG, Shapiro WR, Burger P et al. (2002) The brain tumor cooperative group NIH trial 87-01 A randomized comparison of surgery, external radioherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 51:343–357PubMedGoogle Scholar
  248. Shafron DH, Friedman WA, Buatti JM, Bova FJ, Mendenhall WM (1999) Linac radiosurgery for benign meningiomas. Int J Radiat Oncol Biol Phys 43(2):321–327PubMedGoogle Scholar
  249. Shaw EG, Evans RG, Scheithauer B et al. (1987) Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. Int J Radiat Oncol Biol Phys 13:1457–1462PubMedGoogle Scholar
  250. Shaw E, Scott C, Souhami L et al. (1996) Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of the Radiation Therapy Oncology Group protocol 90-05. Int J Radiat Oncol Biol Phys 34:647–654PubMedGoogle Scholar
  251. Shaw EG, Daumas-Duport C, Scheithauer BW et al. (1989) Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 70:853–861PubMedGoogle Scholar
  252. Shaw E, Scott C, Souhami L et al. (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05. Int Radiat Oncol Biol Phys 47:291–298Google Scholar
  253. Shaw E, Arusell R, Scheithauer B et al. (2002) Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group Study. J Clin Oncol 20:2267–2276PubMedGoogle Scholar
  254. Sheline GF, Wara WM, Smith V (1980) Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6:1215–1288PubMedGoogle Scholar
  255. Shirato H, Takamura A, Tomita M et al. (1997) Stereotactic irradiation without whole-brain irradiation for single brain metastasis. Int J Radiat Oncol Biol Phys 37:385–391PubMedGoogle Scholar
  256. Sklar CA, Constine LS (1995) Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys 31:1113–1121PubMedGoogle Scholar
  257. Sneed PK, Suh JH, Goetsch SJ et al. (2002) A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53:519–526PubMedGoogle Scholar
  258. Soffietti R, Kocher M, Abacioglu UM et al. (2013). A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol. 2013; 31(1):65–72PubMedGoogle Scholar
  259. Souhami L, Seiferheld W, Brachman D et al. (2004) Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of Radiation Therapy Oncology Group 93-05 protocoll. Int J Rad Oncol Biol Phys 60:853–860Google Scholar
  260. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M (2010). Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77(3):655–61PubMedGoogle Scholar
  261. Sperduto CM, Watanabe Y, Mullan J, Hood T, Dyste G, Watts C, Bender GP (2013) A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment J Neurosurg 109 Suppl:87–89Google Scholar
  262. Spetzler RF, Martin NA (1986) A proposed grading system for arteriovenous malformations. J Neurosurg 65:476–483PubMedGoogle Scholar
  263. Spiegelmann R, Lidar Z, Gofman J et al. (2001) Linear accelerator radiosurgery for vestibular schwannoma. J Neurosurg 94:7–13PubMedGoogle Scholar
  264. Spiegelmann R, Nissim O, Menhel J, Alezra D, Pfeffer MR (2002) Linear accelerator radiosurgery for meningiomas in and around the cavernous sinus. Neurosurgery 51(6): 1373–1380PubMedGoogle Scholar
  265. Stafford SL, Pollock BE, Foote RL, Link MJ, Gorman DA, Schomberg PJ, Leavitt JA (2001) Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 49(5):1029–1037PubMedGoogle Scholar
  266. Stummer W, Pichlmeier U, Meinel T, et al. (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7: 392–401PubMedGoogle Scholar
  267. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedGoogle Scholar
  268. Swennen MHJ, Bromberg JEC, Witkamp TD et al. (2004) Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma. J Neurooncol 66:333–339PubMedGoogle Scholar
  269. Stenning SP (1990) Prognostic factors for high-grade malignant glioma: Development of a prognostic index. A report of the Medical Research Council Brain Tumour Working Party. J Neurooncol 9:47–55Google Scholar
  270. Takeda A, Shigematsu N, Suzuki S et al. (1999) Late retinal complications of radiation therapy for nasal and paranasal malignancies: Relationship between irradiated-dose area and severity. Int J Radiat Oncol Biol Phys 44:599–605PubMedGoogle Scholar
  271. Thiel E, Korfel A, Martus P et al. (2010) High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncology 11 :1036–1047PubMedGoogle Scholar
  272. Timmermann B, Kortmann RD, Kühl J et al. (2000) Combined postoperative irradiaton and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys 46:287–295PubMedGoogle Scholar
  273. Timmermann, B, Kortmann, RD, Kühl, J, Rutkowski, S. et al. (2005) Roleof radiotherapy in anaplastic ependymoma in children under 3 years of age: Results of the prospective German brain tumor trials HIT-SKK87 and 92. Radiother. Oncol 77: 278–285Google Scholar
  274. Tishler RB, Loeffler JS, Lunsford LD et al. (1993) Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys 27:215–221PubMedGoogle Scholar
  275. Tomita T, McLone D (1993) Radical resection of childhood craniopharyngiomas. Pediatr Neurosurg 19:6–14PubMedGoogle Scholar
  276. Tsang RW, Brierley JD, Panzarella T et al. (1996) Role of radiation therapy in clinical hormonally-active pituitary adenomas. Radiother Oncol 41:45–53PubMedGoogle Scholar
  277. Tsukada Y, Fouad A, Pickren JW, Lane WW (1983) Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 52:2349–2354PubMedGoogle Scholar
  278. Umsawasdi T, Valdivieso M, Chen TT, Barkley HT Jr, Booser DJ, Chiuten DF, Dhingra HM, Murphy WK, Dixon CL, Farha P, et al. (1984) Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. J Neurooncol 2(3):253–259PubMedGoogle Scholar
  279. Ushio Y, Arito N, Hayakawa T et al. (1991) Chemotherapy of brain metastases from lung carcinoma: a controlled randomized study. Neurosurgery 28:201–209PubMedGoogle Scholar
  280. Utsuki S, Oka H, Tanaka S et al. (2003) Importance of reexamination for medulloblastoma and atypical teratoid/rhabdoid tumor. Acta Neurochir 145:663–666PubMedGoogle Scholar
  281. Valavanis A, Yasargil MG (1998) The endovascular treatment of brain arteriovenous malformations. Adv Tech Stand Neurosurg 24:131–214PubMedGoogle Scholar
  282. van der Kogel AJ (1991) Central nervous system radiation injury in small animal models. In: Gutin PH, Leibel SA, Sheline GE (eds) Radiation injury to the nervous system. Raven, New York, pp 91–112Google Scholar
  283. Van Havenbergh T, Carvalho G, Tatagiba M, Plets C, Samii M (2003) Natural history of petroclival meningiomas. Neurosurgery 52(1):55–62PubMedGoogle Scholar
  284. Van Veelen-Vincent MLC, Pierre-Kahn A, Kalifa C et al. (2002) Ependymoma in childhood: prognostic factors, extent of surgery and adjuvant therapy. J Neurosurg 97:827–835PubMedGoogle Scholar
  285. Verhey LJ, Smith V, Serago CF (1998) Comparison of radiosurgery treatment modalities based on physical dose distributions. Int J Radiat Oncol Biol Phys 40:497–505PubMedGoogle Scholar
  286. Villa S, Vinolas N, Verger E et al. (1998) Efficacy of radiotherapy for malignant gliomas in elderly patients. Int J Radiat Oncol Biol Phys 42(5):977–980PubMedGoogle Scholar
  287. Villavicencio AT, Black PM, Shrieve DC et al. (2001) Linac radiosurgery for skull base meningiomas. Acta Neurochir 143(11):1141–1152PubMedGoogle Scholar
  288. Vladyka V et al. (2000) Radiosurgical treatment of hypophyseal adenomas with the gamma knife: results in a group of 163 patients during a 5-year period. Cas Lek Cesk 139:757–766PubMedGoogle Scholar
  289. Wakelkamp IM, Tan H, Saeed P et al. (2004) Orbital irradiation for Graves’ ophthalmopathy: Is it safe? A long-term follow-up study. Ophthalmology 111:1557–1562PubMedGoogle Scholar
  290. Walker MD, Strike TA, Sheline GE (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5:1725–1731PubMedGoogle Scholar
  291. Walker MD, Green SB, Byar DP et al. (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303:1323–1329PubMedGoogle Scholar
  292. Weinstein JL, Katzenstein HM, Cohn SL (2003) Advances in the diagnosis and treatment of neuroblastoma. Oncologist 8:278–292PubMedGoogle Scholar
  293. Wen BC, Hussey DH, Hitchon PW et al. (1991) The role of radiation therapy in the management of ependymomas of the spinal cord. Int J Radiat Oncol Biol Phys 20:781–786PubMedGoogle Scholar
  294. Wenz F, Steinvorth S, Lohr F et al. (1999) Acute central nervous system (cns) toxicity of total body irradiation (tbi) measured using neuropsychological testing of attention functions. Int J Radiat Oncol Biol Phys 44:891–894PubMedGoogle Scholar
  295. Westphal M, Hilt D, Bortey E et al. (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-oncol 5:6–15Google Scholar
  296. Whittle IR, Basu N, Grant R, Walker M, Gregor A (2002) Management of patients aged 60 years with malignant glioma: good clinical status and radiotherapy determine outcome. Br J Neurosurg 16(4):343–347PubMedGoogle Scholar
  297. Wick W, Hartmann C, Engel C. et al. (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27: 5874–5880PubMedGoogle Scholar
  298. Wick W, Platten M, Meisner C, et al. (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrozytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13: 707–715PubMedGoogle Scholar
  299. Wiegel T, Bottke D, Kreusel KM et al. (2002) External beam radiotherapy of choroidal metastases – final results of a prospective study of the German Cancer Society (ARO 95-08). Radiother Oncol 64:13–18PubMedGoogle Scholar
  300. Wiestler OD, Wolf HK (1995) Die revidierte WHO-Klassifikation und neue Entwicklungen in der Diagnostik zentralnervöser Tumoren. Pathologe 16:17–24Google Scholar
  301. Williams JA (2002) Fractionated stereotactic radiotherapy for acoustic neuromas. Int J Radiat Oncol Biol Phys 54(2): 500–504PubMedGoogle Scholar
  302. Wolden SL, Dunkel IJ, Souweidane MM et al. (2003) Patterns of failure using a conformal radiation therapy tumor bed boost for medulloblastoma. J Clin Oncol 21:3079–3083PubMedGoogle Scholar
  303. Wolff JE, Sajedi M, Brant R et al. (2002) Choroid plexus tumours. Br J Cancer 87:1086–1091PubMedGoogle Scholar
  304. Wong CC, Hao Y (1997) Long-term recovery kinetics of radiation damage in rat spinal cord. Int J Radiat Oncol Biol Phys 37:171–179PubMedGoogle Scholar
  305. Wong ET, Hess KR, Gleason MJ et al. (1999) Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 17:2572–2578PubMedGoogle Scholar
  306. Woo E, Lam K, Yu Yl et al. (1987) Cerebral radionecrosis: is surgery necessary? J Neurol Neurosurg Psych 50:1407–1414Google Scholar
  307. Yen CP, Sheehan J, Patterson G, Steiner L (2006) Gamma knife surgery for metastatic brainstem tumors. J Neurosurg 105(2):213–219PubMedGoogle Scholar
  308. Yung WKA, Albright RE, Olson J et al. (2000) A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83:588–593PubMedGoogle Scholar
  309. Zabel A, Milker-Zabel S, Thilmann C, Zuna I, Rhein B, Wannenmacher M, Debus J (2002 a) Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery: prognostic factors. Lung Cancer 37:87–94PubMedGoogle Scholar
  310. Zabel A, Thilmann C, Milker-Zabel S et al. (2002 b) The role of stereotactically guided conformal radiotherapy for local tumor control of esthesioneuroblastoma. Strahlenther Onkol 178:187–191PubMedGoogle Scholar
  311. Zhang N, Pan L, Wang EM et al. (2000) Radiosurgery for growth hormone-producing pituitary adenoma. J Neurosurg 93 (Suppl 3):6–9PubMedGoogle Scholar
  312. Zierhut D, Flentje M, Adolph J, Erdmann J, Raue F, Wannenmacher M (1995) External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 33:307–314PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • R. Engenhart-Cabillic
    • 1
  • M. W. Groß
    • 2
  • M. Henzel
    • 1
  • A. Zabel-du Bois
    • 3
  • S. Milker-Zabel
    • 4
  • D. Rades
    • 5
  1. 1.Klinik für StrahlentherapieUniversitätsklinik Marburg BaldingerstraßeMarburgDeutschland
  2. 2.Klinik für Strahlentherapie und RadioonkologieUniversitätsspital BaselBaselDeutschland
  3. 3.Radiologische Klinik Abteilung für Radioonkologie und StrahlentherapieUniversitätsklinikum HeidelbergHeidelbergDeutschland
  4. 4.Abteilung für Strahlentherapie (Radio-Onkologie) Klinikum Mutterhaus der BorromäerinnenAkademisches Lehrkrankenhaus der Johannes Gutenberg-Universität MainzTrierDeutschland
  5. 5.Klinik für StrahlentherapieUniversität LübeckLübeckDeutschland

Personalised recommendations